Candesartan in Heart Failure-Assessment of Reduction in Mortality and Morbidity (CHARM): Rationale and design

Journal of Cardiac Failure

Volumn 5, Issue 3, 1999, Pages 276-282

  Swedberg, K ^a   Pfeffer, M ^a   Granger, C ^a   Held, P ^a   McMurray, J ^a   Ohlin, G ^a   Olofsson, B ^a   Ostergren, J ^a   Yusuf, S ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ACE inhibition; AT1 receptor blockers; Congestive heart failure; Left ventricular function

Indexed keywords

CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CONGESTIVE HEART FAILURE; DRUG EFFECT; DRUG EFFICACY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW;

EID: 0032834737     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(99)90013-1     Document Type: Article

References (24)